ETC
ANIP icon

Exchange Traded Concepts’s ANI Pharmaceuticals ANIP Stock Holding History

Exchange Traded Concepts’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$880K Sell
10,632
-159
-1% -$12.8K ﹤0.01% 984
2026
Q1 		$830K Buy
10,791
+2,565
+31% +$200K 0.01% 883
2025
Q4 		$649K Sell
8,226
-240
-3% -$20.8K ﹤0.01% 958
2025
Q3 		$775K Buy
+8,466
New +$690K 0.01% 903
2025
Q1 		– Sell
-12,366
Closed -$684K – 1265
2024
Q4 		$684K Buy
12,366
+310
+3% +$17.8K 0.01% 730
2024
Q3 		$719K Buy
12,056
+2,072
+21% +$126K 0.02% 686
2024
Q2 		$636K Buy
9,984
+477
+5% +$31K 0.02% 619
2024
Q1 		$657K Buy
+9,507
New +$574K 0.02% 561

Other funds holding ANIP

MMA
Mizuho Markets Americas New York $6.37B AUM 47.14% 1-Year Est. Return
MCM
Marathon Capital Management Hunt Valley, Maryland $494M AUM 42.6% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
OLA
Oliver Luxxe Assets Gladstone, New Jersey $680M AUM 47.51% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
EA
Ellsworth Advisors Hudson, Ohio $609M AUM 52.37% 1-Year Est. Return
BCM
BTC Capital Management Des Moines, Iowa $1.65B AUM 27.85% 1-Year Est. Return

Exchange Traded Concepts's ANIP Position: Q2 2026 in Review

Exchange Traded Concepts reduced its ANI Pharmaceuticals (ANIP) stake by 1.5% in Q2 2026, selling an estimated $12.8K and leaving 10,632 shares worth $880K. The position accounts for ﹤0.01% of the portfolio, ranked #984.

Exchange Traded Concepts first reported a position in ANIP in Q1 2024 and has held it in 8 quarters since. 39 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • Exchange Traded Concepts held 10,632 shares of ANI Pharmaceuticals worth $880K as of Q2 2026.
  • Exchange Traded Concepts sold 159 ANI Pharmaceuticals shares in Q2 2026, an estimated $12.8K.
  • ANI Pharmaceuticals made up ﹤0.01% of Exchange Traded Concepts's portfolio in Q2 2026, its #984 holding.
  • Exchange Traded Concepts first reported a position in ANI Pharmaceuticals in Q1 2024 and has held it in 8 quarters since.
  • 39 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Exchange Traded Concepts's 13F filing for Q2 2026, filed 22 Jul 2026.